Loss of DIAPH3, which encodes the mDia2 protein, occurs in primary and metastatic prostate cancer tumors, hepatocarcinoma, breast carcinoma, and in an OvCa progression model [10], [29], [30], [44]. Here, DIAPH3 is linked to breast carcinoma.